Abstract
Expression of aberrantly spliced BRAF V600E isoforms (BRAF V600E Delta Ex) mediates resistance in 13%-30% of melanoma patients progressing on RAF inhi......
小提示:本篇文献需要登录阅读全文,点击跳转登录